LGR5 and breast carcinoma: As EMT is commonly involved in cell mobility changes, and LGR5 has been identified as involved in EMT progression in breast cancer 22 and hepatocellular carcinoma 27, we investigated the expression of EMT markers and EMT‐related transcription factors by Western blotting.